CDCA2 and hepatocellular carcinoma: In conclusion, we found that CDCA2 was a new diagnostic marker for HCC through bioinformatic analysis and clinical samples; overexpression of CDCA2 reflected poor pathological grading, staging, and clinical prognosis of HCC patients.